Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients

A. C. Tsiatis, B. Manes, C. Calder, David D Billheimer, K. S. Wilkerson, Haydar Frangoul

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 and November 2002. When VRE was identified, the patients were placed on strict contact isolation. VRE was detected in 15 patients (24.6%). The median age was 3.6 years (range 0.6-18.5 years). Of the 15, 13 (87%) received an allogeneic transplant (six unrelated and seven related). Five of the 15 (33%) colonized patients developed VRE bacteremia. The bacteremia resolved in all five patients after therapy with quinupristin/dalfopristin; three patients required central line removal. Four patients died (38-153 days) post-SCT due to relapse or transplant complication not related to VRE. Of the 11 surviving patients, seven cleared the colonization at a median of 144 days (range 61-198 days) postcolonization. Four patients remain colonized at 68-702 days after the first positive culture. Intestinal colonization with VRE occurred commonly in pediatric SCT patients. Although the morbidity from VRE was not substantial, transplant patients were colonized for prolonged periods. Our results indicate that surveillance for VRE is an effective way to identify colonized patients and may lead to a decrease in transmission to other patients.

Original languageEnglish (US)
Pages (from-to)937-941
Number of pages5
JournalBone Marrow Transplantation
Volume33
Issue number9
DOIs
StatePublished - May 2004
Externally publishedYes

Fingerprint

Stem Cells
Pediatrics
Transplants
Incidence
Bacteremia
Vancomycin-Resistant Enterococci
Morbidity
Recurrence

Keywords

  • Infection control
  • Pediatric stem cell transplantation
  • Vancomycin-resistant enterococcus

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. / Tsiatis, A. C.; Manes, B.; Calder, C.; Billheimer, David D; Wilkerson, K. S.; Frangoul, Haydar.

In: Bone Marrow Transplantation, Vol. 33, No. 9, 05.2004, p. 937-941.

Research output: Contribution to journalArticle

Tsiatis, A. C. ; Manes, B. ; Calder, C. ; Billheimer, David D ; Wilkerson, K. S. ; Frangoul, Haydar. / Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. In: Bone Marrow Transplantation. 2004 ; Vol. 33, No. 9. pp. 937-941.
@article{beda197918de4f5b983f73fa34acd856,
title = "Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients",
abstract = "Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 and November 2002. When VRE was identified, the patients were placed on strict contact isolation. VRE was detected in 15 patients (24.6{\%}). The median age was 3.6 years (range 0.6-18.5 years). Of the 15, 13 (87{\%}) received an allogeneic transplant (six unrelated and seven related). Five of the 15 (33{\%}) colonized patients developed VRE bacteremia. The bacteremia resolved in all five patients after therapy with quinupristin/dalfopristin; three patients required central line removal. Four patients died (38-153 days) post-SCT due to relapse or transplant complication not related to VRE. Of the 11 surviving patients, seven cleared the colonization at a median of 144 days (range 61-198 days) postcolonization. Four patients remain colonized at 68-702 days after the first positive culture. Intestinal colonization with VRE occurred commonly in pediatric SCT patients. Although the morbidity from VRE was not substantial, transplant patients were colonized for prolonged periods. Our results indicate that surveillance for VRE is an effective way to identify colonized patients and may lead to a decrease in transmission to other patients.",
keywords = "Infection control, Pediatric stem cell transplantation, Vancomycin-resistant enterococcus",
author = "Tsiatis, {A. C.} and B. Manes and C. Calder and Billheimer, {David D} and Wilkerson, {K. S.} and Haydar Frangoul",
year = "2004",
month = "5",
doi = "10.1038/sj.bmt.1704462",
language = "English (US)",
volume = "33",
pages = "937--941",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients

AU - Tsiatis, A. C.

AU - Manes, B.

AU - Calder, C.

AU - Billheimer, David D

AU - Wilkerson, K. S.

AU - Frangoul, Haydar

PY - 2004/5

Y1 - 2004/5

N2 - Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 and November 2002. When VRE was identified, the patients were placed on strict contact isolation. VRE was detected in 15 patients (24.6%). The median age was 3.6 years (range 0.6-18.5 years). Of the 15, 13 (87%) received an allogeneic transplant (six unrelated and seven related). Five of the 15 (33%) colonized patients developed VRE bacteremia. The bacteremia resolved in all five patients after therapy with quinupristin/dalfopristin; three patients required central line removal. Four patients died (38-153 days) post-SCT due to relapse or transplant complication not related to VRE. Of the 11 surviving patients, seven cleared the colonization at a median of 144 days (range 61-198 days) postcolonization. Four patients remain colonized at 68-702 days after the first positive culture. Intestinal colonization with VRE occurred commonly in pediatric SCT patients. Although the morbidity from VRE was not substantial, transplant patients were colonized for prolonged periods. Our results indicate that surveillance for VRE is an effective way to identify colonized patients and may lead to a decrease in transmission to other patients.

AB - Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 and November 2002. When VRE was identified, the patients were placed on strict contact isolation. VRE was detected in 15 patients (24.6%). The median age was 3.6 years (range 0.6-18.5 years). Of the 15, 13 (87%) received an allogeneic transplant (six unrelated and seven related). Five of the 15 (33%) colonized patients developed VRE bacteremia. The bacteremia resolved in all five patients after therapy with quinupristin/dalfopristin; three patients required central line removal. Four patients died (38-153 days) post-SCT due to relapse or transplant complication not related to VRE. Of the 11 surviving patients, seven cleared the colonization at a median of 144 days (range 61-198 days) postcolonization. Four patients remain colonized at 68-702 days after the first positive culture. Intestinal colonization with VRE occurred commonly in pediatric SCT patients. Although the morbidity from VRE was not substantial, transplant patients were colonized for prolonged periods. Our results indicate that surveillance for VRE is an effective way to identify colonized patients and may lead to a decrease in transmission to other patients.

KW - Infection control

KW - Pediatric stem cell transplantation

KW - Vancomycin-resistant enterococcus

UR - http://www.scopus.com/inward/record.url?scp=2442688027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442688027&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1704462

DO - 10.1038/sj.bmt.1704462

M3 - Article

VL - 33

SP - 937

EP - 941

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 9

ER -